about
Fundamental aspects of solid dispersion technology for poorly soluble drugsExtrusion - back to the future: Using an established technique to reform automated chemical synthesisA study on the impact of hydroxypropyl methylcellulose on the viscosity of PEG melt suspensions using surface plots and principal component analysis.Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technologyInfluence of Molecular Weight of Carriers and Processing Parameters on the Extrudability, Drug Release, and Stability of Fenofibrate Formulations Processed by Hot-Melt ExtrusionConjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.Interactions between drugs and polymers influencing hot melt extrusion.Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.Granulation techniques and technologies: recent progressesHot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.Investigation of Thermal and Viscoelastic Properties of Polymers Relevant to Hot Melt Extrusion, IV: Affinisol™ HPMC HME Polymers.Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing ParametersHot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperineWetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation.Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product.Melt extrusion with poorly soluble drugs - An integrated review.Continuous low-dose feeding of highly active pharmaceutical ingredients in hot-melt extrusion.Increased dissolution rates of carbamazepine--gluconolactone binary blends processed by hot melt extrusion.Preparation, characterizations and anti-pollutant activity of 7,3′,4′-trihydroxyisoflavone nanoparticles in particulate matter-induced HaCaT keratinocytes.
P2860
Q26822873-00FD9117-2A47-43EA-89A3-4BBA240BA314Q28817217-2ADB9298-67C8-48C5-9318-1C9536AAD686Q35209961-BB0E30CD-FB4B-4459-83C6-4D7457D8CCCFQ35505617-A226D1F1-D24A-4B43-B007-0803BC4D08B6Q36343942-B2246EF0-388E-46E1-8549-8A0EFCEBE7EEQ36614773-846AE754-DD18-4008-963E-CBE8BB42D5C7Q38170190-65DF938D-BB83-4E28-AA94-8387DEC759AEQ38257177-E7BE4107-2D23-43A9-ABBA-9D33AF1A0EE7Q38435033-B3DC7CEB-D895-40A7-BE3E-6FF99F2261EFQ38544558-C05686AA-3795-49C9-B5A0-0EFDECF039EEQ38619405-39091607-DB99-4DC6-999A-F1925C42FCB1Q38619454-118576D5-9933-4CFF-A310-5E4EF7507992Q38619531-12ACE532-023F-4FB0-8144-967FEC3EDA0FQ38619541-9EEC26B1-3140-4E13-8D53-757EA605F99FQ42433654-181E17E4-7CD9-4A61-8164-89CEF893485EQ42646407-A3B37944-6DBC-4505-AE23-4F0BB663511FQ43728136-3D7E0087-B6A4-4040-BCDA-F5D005F597FDQ45326562-95D2C6B9-5027-4590-9050-3046688717BCQ48034195-DE7C624A-CE26-4D7B-95AA-70BE4C6138E1Q48062570-B35FEF9F-6F10-4B43-96CF-C24CEBA0408DQ48384525-1A42B53E-EEB9-4806-8827-AAB29907854BQ49083280-B2BE25D4-DFFB-4DBC-93BE-9DFC5629877FQ50161058-90A48015-1263-49A5-87A5-04BE1337AC00Q51566498-681BB719-4E68-4D3A-8934-AFB09AFABD14Q53295583-1E5FD037-F821-42B2-84FC-E23141C3FC61Q55109237-F2C47579-8C5E-4D44-8C4C-2878D82EFEE8
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Melt extrusion with poorly soluble drugs.
@en
type
label
Melt extrusion with poorly soluble drugs.
@en
prefLabel
Melt extrusion with poorly soluble drugs.
@en
P2093
P1476
Melt extrusion with poorly soluble drugs.
@en
P2093
Jiannan Lu
Michael A Repka
Sejal Shah
Sindhuri Maddineni
P304
P356
10.1016/J.IJPHARM.2012.11.001
P407
P577
2012-11-20T00:00:00Z